本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

RESPIRI LTD

0.033
+0.000
成交量:- -
成交額:- -
市值:5,198.41萬
市盈率:-5.09
高:0.033
開:0.033
低:0.033
收:0.033
資料載入中...

公司資料

公司名字:
RESPIRI LTD
交易所:
ASX
成立時間:
- -
員工人數:
- -
公司地址:
- -
郵編:
- -
電話:
- -
傳真:
- -
簡介:
Respiri Limited, a health technology company, researches, develops, and commercializes, medical devices in Australia and Israel. The company produces and sells mobile health applications. Its products include Wheezo, a mobile app, which has asthma management diary, medication usage and reminders, and symptoms and triggers to help asthma sufferers; Wholter, a device for home ambulatory recording of nocturnal wheeze and cough; and AirSonea, a digital stethoscope that is paired to a smartphone app to record breathing sounds accurately. The company also offers PulmoTrack, a computerized wheeze detection product designed for hospital/clinical based real-time monitoring of wheeze and cough in the management of acute asthma in the ER and ICU, and for pediatric pulmonary function testing and sleep labs; and SonoSentry, an over-the-counter wheeze-detection device. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited was incorporated in 1987 and is based in Melbourne, Australia.